<p><b>Comparison of the quantification of minority resistant variants (MRV) using SmartGene<sup>®</sup> (SG) and AVA<sup>®</sup> pipeline analysis for protease mutations (A,B) and Reverse Transcriptase (RT) (C, D) mutations after excluding two major discrepancies</b>. Minority resistant variants frequencies were depicted according to linear regression (A, C) and Bland-Altman (B, D) analyses. For Bland-Altman analysis, y-axis indicates the percentage of difference in MRV frequency measurements between AVA<sup>®</sup> and SG<sup>®</sup> analysis and x-axis indicates the mean of the two measurements. All MRV detected by both software were included in this analysis. The 95% confidence intervals limits of agreement were calculated. Mean, upper a...
A hybridization-based point-of-care (POC) assay for HIV-1 drug resistance would be useful in low- an...
International audienceSanger population sequencing (SPS) is the reference technique to monitor HIV-1...
Objectives: To est. the relative efficiency of transmission of different HIV-1 drug-resistance mutat...
<p><b>Comparison of the quantification of minority resistant variants (MRV) using SmartGene<sup>®</s...
OBJECTIVE:Reliable detection of HIV minority resistant variants (MRVs) requires bioinformatics analy...
OBJECTIVES: To compare three methods for using HIV-1 genotype to predict antiretroviral drug suscep...
Summary: Several rules-based algorithms have been developed to interpret results of HIV-1 genotypic ...
Objectives: To compare three methods for using HIV-1 genotype to predict antiretroviral drug suscept...
Background: Detecting clinically relevant drug resistance mutations (DRMs), especially those conferr...
Background: The routine use of drug resistance testing provides an abundant source of HIV-1 sequence...
Objective: This study utilized genotypic and in-house recombinant virus phenotypic assays to examine...
Next-generation sequencing (NGS) is increasingly used for HIV-1 drug resistance genotyping. NGS meth...
The sensitivity and discriminatory power of the 151 and 215 amplification refractory mutation system...
SummaryObjectiveThis study utilized genotypic and in-house recombinant virus phenotypic assays to ex...
Determining the phenotypic impacts of reverse transcriptase (RT) mutations on individual nucleoside ...
A hybridization-based point-of-care (POC) assay for HIV-1 drug resistance would be useful in low- an...
International audienceSanger population sequencing (SPS) is the reference technique to monitor HIV-1...
Objectives: To est. the relative efficiency of transmission of different HIV-1 drug-resistance mutat...
<p><b>Comparison of the quantification of minority resistant variants (MRV) using SmartGene<sup>®</s...
OBJECTIVE:Reliable detection of HIV minority resistant variants (MRVs) requires bioinformatics analy...
OBJECTIVES: To compare three methods for using HIV-1 genotype to predict antiretroviral drug suscep...
Summary: Several rules-based algorithms have been developed to interpret results of HIV-1 genotypic ...
Objectives: To compare three methods for using HIV-1 genotype to predict antiretroviral drug suscept...
Background: Detecting clinically relevant drug resistance mutations (DRMs), especially those conferr...
Background: The routine use of drug resistance testing provides an abundant source of HIV-1 sequence...
Objective: This study utilized genotypic and in-house recombinant virus phenotypic assays to examine...
Next-generation sequencing (NGS) is increasingly used for HIV-1 drug resistance genotyping. NGS meth...
The sensitivity and discriminatory power of the 151 and 215 amplification refractory mutation system...
SummaryObjectiveThis study utilized genotypic and in-house recombinant virus phenotypic assays to ex...
Determining the phenotypic impacts of reverse transcriptase (RT) mutations on individual nucleoside ...
A hybridization-based point-of-care (POC) assay for HIV-1 drug resistance would be useful in low- an...
International audienceSanger population sequencing (SPS) is the reference technique to monitor HIV-1...
Objectives: To est. the relative efficiency of transmission of different HIV-1 drug-resistance mutat...